Cargando…
Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells
Trastuzumab emtansine (T-DM1) is an antibody drug conjugate (ADC) that was recently approved for the treatment of HER-2-positive metastatic breast cancer. The drug sensitivity of ADCs depends mainly on the internalization efficiency of the drug. Caveolin-1 was shown to promote T-DM1 internalization...
Autores principales: | Chung, Yuan-Chiang, Chang, Ching-Ming, Wei, Wan-Chen, Chang, Ting-Wei, Chang, King-Jen, Chao, Wei-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834501/ https://www.ncbi.nlm.nih.gov/pubmed/29500444 http://dx.doi.org/10.1038/s41598-018-22250-8 |
Ejemplares similares
-
Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1)
por: Chung, Yuan-Chiang, et al.
Publicado: (2015) -
The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation
por: Lee, Chih-Yuan, et al.
Publicado: (2017) -
Clinical consequences of head and neck free-flap reconstructions in the DM population
por: Chiu, Ting-Han, et al.
Publicado: (2021) -
The influence of a caveolin-1 mutant on the function of P-glycoprotein
por: Lee, Chih-Yuan, et al.
Publicado: (2016) -
Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
por: Yang, Su-Jung, et al.
Publicado: (2013)